(19)
(11) EP 4 816 522 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24895253.3

(22) Date of filing: 24.10.2024
(51) International Patent Classification (IPC): 
C12N 5/071(2010.01)
C12N 5/00(2006.01)
A61K 35/39(2015.01)
G01N 33/50(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/39; C12N 5/0676; C12N 2501/115; C12N 2501/727; C12N 2501/16; C12N 2501/415; C12N 2501/119; C12N 2501/155; C12N 2501/385; C12N 2501/11; C12N 2506/02; C12N 2506/45
(86) International application number:
PCT/CA2024/051410
(87) International publication number:
WO 2025/111693 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 US 202363604826 P

(71) Applicant: University Health Network
Toronto, Ontario M5G 2C4 (CA)

(72) Inventors:
  • MCGAUGH, Emily Catherine
    Brampton, Ontario L6Z 2W6 (CA)
  • NOSTRO, Maria Cristina
    Toronto, Ontario M5J 2Z7 (CA)
  • MISRA, Paraish Shivam
    Toronto, Ontario M4N 0A4 (CA)

(74) Representative: AWA Sweden AB 
Box 5117
200 71 Malmö
200 71 Malmö (SE)

   


(54) GENERATION OF ENTEROCHROMAFFIN AND PANCREATIC CELLS